Sight Sciences, Inc. SGHT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Dry Eye | $2.6M+58.6% | $1.64M+34.5% | $1.22M-52.3% | $2.56M-23.7% | $3.35M-15.5% | |
| Surgical Glaucoma | $76.95M+1.6% | $75.72M+1.2% | $74.83M+1.5% | $73.75M-1.4% | $74.76M-1.5% | |
| Gross Profit by Business | ||||||
| Dry Eye | $1.67M+71.8% | $972K+53.8% | $632K-51.0% | $1.29M-23.5% | $1.69M-8.0% | |
| Surgical Glaucoma | $66.88M+1.8% | $65.69M+1.4% | $64.81M+1.5% | $63.86M-2.1% | $65.22M-1.9% | |
| Cost of Goods Sold by Business | ||||||
| Dry Eye | $929K+39.3% | $667K+13.6% | $587K-53.7% | $1.27M-23.9% | $1.66M-22.0% | |
| Surgical Glaucoma | $10.07M+0.4% | $10.03M0.0% | $10.03M+1.4% | $9.89M+3.7% | $9.54M+0.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Sight Sciences, Inc. break its business down?
- Sight Sciences, Inc. (SGHT) reports revenue by business across 2 parts — Dry Eye and Surgical Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Sight Sciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Sight Sciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
